United Therapeutics Corporation (UTHR) — Working Capital to Net Assets Ratio

Latest as of September 2025: 44.7%

United Therapeutics Corporation (UTHR) has a Working Capital to Net Assets ratio of 44.7% as of September 2025. Working capital of $2.95 Billion (current assets of $3.49 Billion minus current liabilities of $546.30 Million) is measured against net assets of $6.59 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See United Therapeutics Corporation (UTHR) balance sheet quality index to measure how much of total assets are equity-financed.

WC/NA Ratio

44.7%
Working Capital / Net Assets

Working Capital

$2.95 Billion
USD

Current Assets

$3.49 Billion
USD

Current Liabilities

$546.30 Million
USD

United Therapeutics Corporation Working Capital to Net Assets (1998–2024)

This chart shows how United Therapeutics Corporation's Working Capital to Net Assets ratio has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the ratio stands at 44.7%, reflecting working capital of $2.95 Billion against net assets of $6.59 Billion USD. Check United Therapeutics Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for United Therapeutics Corporation (1998–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for United Therapeutics Corporation from 1998 to 2024, covering 27 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see United Therapeutics Corporation market cap and net worth.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 48.7% $3.14 Billion $6.44 Billion $3.87 Billion $738.10 Million ▲ +2.8 pp
2023 45.9% $2.75 Billion $5.98 Billion $3.55 Billion $804.40 Million ▼ -17.4 pp
2022 63.3% $3.04 Billion $4.80 Billion $3.38 Billion $343.20 Million ▲ +12.3 pp
2021 51.0% $2.02 Billion $3.96 Billion $2.32 Billion $305.40 Million ▼ -3.3 pp
2020 54.3% $1.84 Billion $3.40 Billion $2.17 Billion $323.30 Million ▲ +3.9 pp
2019 50.4% $1.40 Billion $2.78 Billion $1.86 Billion $463.00 Million ▼ -3.1 pp
2018 53.5% $1.49 Billion $2.79 Billion $1.77 Billion $276.60 Million ▲ +5.8 pp
2017 47.7% $1.00 Billion $2.10 Billion $1.45 Billion $444.70 Million ▼ -10.9 pp
2016 58.7% $1.09 Billion $1.86 Billion $1.42 Billion $332.50 Million ▲ +6.5 pp
2015 52.2% $834.51 Million $1.60 Billion $1.28 Billion $440.82 Million ▲ +15.0 pp
2014 37.1% $469.89 Million $1.27 Billion $974.20 Million $504.31 Million ▲ +20.2 pp
2013 17.0% $221.34 Million $1.30 Billion $909.01 Million $687.67 Million ▼ -27.9 pp
2012 44.9% $491.71 Million $1.09 Billion $668.47 Million $176.75 Million ▲ +8.0 pp
2011 36.9% $349.88 Million $948.49 Million $562.46 Million $212.58 Million ▼ -1.2 pp
2010 38.1% $336.37 Million $883.89 Million $765.05 Million $428.69 Million ▲ +38.9 pp
2009 -0.9% $-5.68 Million $653.01 Million $324.51 Million $330.19 Million ▼ -48.1 pp
2008 47.2% $239.62 Million $507.70 Million $297.45 Million $57.83 Million ▲ +20.3 pp
2007 26.9% $79.70 Million $295.79 Million $352.46 Million $272.76 Million ▼ -99.2 pp
2006 126.2% $258.12 Million $204.61 Million $277.37 Million $19.25 Million ▲ +70.8 pp
2005 55.3% $152.23 Million $275.10 Million $166.76 Million $14.52 Million ▲ +4.9 pp
2004 50.4% $96.63 Million $191.64 Million $110.49 Million $13.86 Million ▲ +3.3 pp
2003 47.2% $79.10 Million $167.76 Million $89.72 Million $10.62 Million ▼ -30.1 pp
2002 77.2% $132.55 Million $171.66 Million $141.86 Million $9.31 Million ▲ +47.6 pp
2001 29.6% $58.20 Million $196.40 Million $69.00 Million $10.80 Million ▼ -60.1 pp
2000 89.7% $210.63 Million $234.74 Million $222.12 Million $11.49 Million ▼ 0.0 pp
1999 89.7% $48.10 Million $53.60 Million $52.70 Million $4.60 Million ▼ -0.1 pp
1998 89.8% $15.00 Million $16.70 Million $16.80 Million $1.80 Million
pp = percentage points